Moderna will not enforce the patents it gained for its experimental COVID-19 vaccine and will license its COVID-19 vaccine intellectual property to other drugmakers after the pandemic is declared over, the drugmaker announced Oct. 8.
Pharmacy
Eli Lilly and the Bill & Melinda Gates Foundation will partner to supply the drugmaker's COVID-19 antibody drug to low- and middle-income countries, Eli Lilly said Oct. 8.
Remdesivir shortened COVID-19 patient recovery time by five days, according to final data from a phase 3 trial published Oct. 8 in the New England Journal of Medicine.
U.S. health officials are working quickly to get an $8 billion plan to provide $200 drug cards to all Medicare patients by Election Day, five health officials told Politico.
President Donald Trump and White House Chief of Staff Mark Meadows are both urging the FDA to quickly grant an emergency use authorization for Regeneron's antibody drug, which the president received as a treatment for COVID-19, The Washington Post reported.
In the last two months, six hospitals or health systems have opened or announced plans to open pharmacies:
Kent State University in Ohio has partnered with CVS Health to provide free COVID-19 testing for all students, faculty and staff starting Oct. 12 through the spring semester.
Jorge David Gutierrez, a recruiter for Moderna's COVID-19 vaccine trial based in Boston's Brigham and Women's Hospital, has encountered a significant amount of distrust among the public while trying to enroll participants, he told STAT.
Seventy-two percent of Americans said they would probably or definitely receive a flu shot during the current flu season, according to results released Oct. 8 from a survey conducted by The Harris Poll on behalf of Walgreens.
Walgreens will offer expanded clinical services in its pharmacies in Chicago, beginning in the city's underserved neighborhoods on the South Side, the company said Oct. 7.